EUCTR2005-002900-40-ES进行中（未招募）1 期
BENEFIT-OL / Estudio abierto de extensión a largo plazo en pacientes con hipertensión pulmonar tromboembólica crónica (HPTC) inoperable que hayan completado el protocolo AC-052-366/BENEFIT - BENEFIT-O
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •·Pacientes que hayan completado el período de tratamiento de 16 semanas del protocolo AC-052-366/BENEFIT
- •·Firma del consentimiento informado antes de iniciar ningún procedimiento dictado por el estudio
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •·Cualquier violación grave del protocolo AC-052-366/BENEFIT
- •·Embarazo o lactancia
研究者
相似试验
进行中（未招募）
1 期
Estudio de extensión, a largo plazo, abierto, dosis flexible, que evalúa la seguridad y tolerabilidad deLu AA21004 en pacientes con trastorno depresivo mayor. - Not applicableTrastorno Depresivo MayorMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2007-004992-21-ESH. Lundbeck A/S550
进行中（未招募）
1 期
An open label, long-term extension study to evaluate the safety and efficacy of CRN00808 in subjects with acromegaly (ACROBAT ADVANCE)MedDRA version: 20.0Level: PTClassification code: 10000599Term: Acromegaly Class: 100000004860AcromegalyCTIS2024-511921-75-00Crinetics Pharmaceuticals Inc.31
未知
2 期
ong-term study of LCZ696 treatment in patients with essential hypertensioJPRN-jRCT2080221787ovartis Pharma K.K.344
进行中（未招募）
不适用
Study of the safety of the long-acting opioid pain medication Oxycodone hydrochloride in children who have been treated previously with opioid pain medication who completed the OTR3001 studyEUCTR2011-002235-26-GBPurdue Pharma L.P.154
进行中（未招募）
不适用
Study of the safety of the long-acting opioid pain medication Oxycodone hydrochloride in children who have been treated previously with opioid pain medication who completed the OTR3001 studyEUCTR2011-002235-26-GRPurdue Pharma L.P.135